CXCL9 and melanoma: Taken together, these results demonstrated that NPTyr-C9AP could mobilize melanoma cells to coexpress CXCL9 and αPD-L1 to enhance both the recruitment and activation of T cells, thereby resulting in synergistic tumor-killing effects.